| dc.contributor.author |
Ploegh, Hidde |
|
| dc.contributor.author |
Sun, Jiusong |
|
| dc.contributor.author |
Hartvigsen, Karsten |
|
| dc.contributor.author |
Chou, Meng-Yun |
|
| dc.contributor.author |
Zhang, Yadong |
|
| dc.contributor.author |
Sukhova, Galina K. |
|
| dc.contributor.author |
Zhang, Jie |
|
| dc.contributor.author |
Lopez-Ilasaca, Marco |
|
| dc.contributor.author |
Diehl, Cody J. |
|
| dc.contributor.author |
Yakov, Niva |
|
| dc.contributor.author |
Harats, Dror |
|
| dc.contributor.author |
George, Jacob |
|
| dc.contributor.author |
Witztum, Joseph L. |
|
| dc.contributor.author |
Libby, Peter |
|
| dc.contributor.author |
Shi, Guo-Ping |
|
| dc.date.accessioned |
2012-10-25T20:54:32Z |
|
| dc.date.available |
2012-10-25T20:54:32Z |
|
| dc.date.issued |
2010-08 |
|
| dc.date.submitted |
2009-07 |
|
| dc.identifier.issn |
0009-7322 |
|
| dc.identifier.issn |
1524-4539 |
|
| dc.identifier.uri |
http://hdl.handle.net/1721.1/74265 |
|
| dc.description |
August 25, 2010 |
en_US |
| dc.description.abstract |
Background: Adaptive immunity and innate immunity play important roles in atherogenesis. Invariant chain (CD74) mediates antigen-presenting cell antigen presentation and T-cell activation. This study tested the hypothesis that CD74-deficient mice have reduced numbers of active T cells and resist atherogenesis.
Methods and Results: In low-density lipoprotein receptor–deficient (Ldlr[superscript −/−]) mice, CD74 deficiency (Ldlr[superscript −/−]Cd74[superscript −/−]) significantly reduced atherosclerosis and CD25+-activated T cells in the atheromata. Although Ldlr[superscript −/−]Cd74[superscript −/−] mice had decreased levels of plasma immunoglobulin (Ig) G1, IgG2b, and IgG2c against malondialdehyde-modified LDL (MDA-LDL), presumably as a result of impaired antigen-presenting cell function, Ldlr[superscript −/−]Cd74[superscript −/−] mice showed higher levels of anti–MDA-LDL IgM and IgG3. After immunization with MDA-LDL, Ldlr[superscript −/−]Cd74[superscript −/−] mice had lower levels of all anti–MDA-LDL Ig isotypes compared with Ldlr[superscript −/−] mice. As anticipated, only Ldlr[superscript −/−] splenocytes responded to in vitro stimulation with MDA-LDL, producing Th1/Th2 cytokines. Heat shock protein-65 immunization enhanced atherogenesis in Ldlr[superscript −/−] mice, but Ldlr[superscript −/−] Cd74[superscript −/−] mice remained protected. Compared with Ldlr[superscript −/−] mice, Ldlr[superscript −/−]Cd74[superscript −/−] mice had higher anti–MDA-LDL autoantibody titers, fewer lesion CD25+-activated T cells, impaired release of Th1/Th2 cytokines from antigen-presenting cells after heat shock protein-65 stimulation, and reduced levels of all plasma anti–heat shock protein-65 Ig isotypes. Cytofluorimetry of splenocytes and peritoneal cavity cells of MDA-LDL– or heat shock protein-65–immunized mice showed increased percentages of autoantibody-producing marginal zone B and B-1 cells in Ldlr[superscript −/−]Cd74[superscript −/−] mice compared with Ldlr[superscript −/−] mice.
Conclusions: Invariant chain deficiency in Ldlr[superscript −/−] mice reduced atherosclerosis. This finding was associated with an impaired adaptive immune response to disease-specific antigens. Concomitantly, an unexpected increase in the number of innate-like peripheral B-1 cell populations occurred, resulting in increased IgM/IgG3 titers to the oxidation-specific epitopes. |
en_US |
| dc.language.iso |
en_US |
|
| dc.publisher |
Ovid Technologies (Wolters Kluwer) -American Heart Association |
en_US |
| dc.relation.isversionof |
http://dx.doi.org/10.1161/circulationaha.109.891887 |
en_US |
| dc.rights |
Creative Commons Attribution-Noncommercial-Share Alike 3.0 |
en_US |
| dc.rights.uri |
http://creativecommons.org/licenses/by-nc-sa/3.0/ |
en_US |
| dc.source |
PMC |
en_US |
| dc.title |
Deficiency of Antigen Presenting Cell Invariant Chain Reduces Atherosclerosis in Mice |
en_US |
| dc.type |
Article |
en_US |
| dc.identifier.citation |
Sun, J. et al. “Deficiency of Antigen-Presenting Cell Invariant Chain Reduces Atherosclerosis in Mice.” Circulation 122.8 (2010): 808–820. |
en_US |
| dc.contributor.department |
Massachusetts Institute of Technology. Dept. of Biology |
en_US |
| dc.contributor.department |
Whitehead Institute for Biomedical Research |
en_US |
| dc.contributor.mitauthor |
Ploegh, Hidde |
|
| dc.relation.journal |
Circulation |
en_US |
| dc.identifier.mitlicense |
OPEN_ACCESS_POLICY |
en_US |
| dc.eprint.version |
Author's final manuscript |
en_US |
| dc.type.uri |
http://purl.org/eprint/type/JournalArticle |
en_US |
| eprint.status |
http://purl.org/eprint/status/PeerReviewed |
en_US |
| dspace.orderedauthors |
Sun, J.; Hartvigsen, K.; Chou, M.-Y.; Zhang, Y.; Sukhova, G. K.; Zhang, J.; Lopez-Ilasaca, M.; Diehl, C. J.; Yakov, N.; Harats, D.; George, J.; Witztum, J. L.; Libby, P.; Ploegh, H.; Shi, G.-P. |
en |